Regeneron Antibodies Prevent Symptomatic COVID-19 In Interim Phase III Data
Efficacy Data On Casirivimab/Imdevimab In Mutant Strains Forthcoming
Interim data from Regeneron's Phase III study show its antibody cocktail is effective at preventing symptomatic COVID-19. • Source: Shutterstock 
